Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: John Brickman who wrote (5514)	3/25/1998 10:57:00 AM
From: Cosmo Daisey	Read Replies (1) \| Respond to of 18691

John, biz.yahoo.com Short the news spike don't cover. The price was run up because someone had the news before the public announcment and they are selling today. The run up is over, the news is already in the price. Short today and cover this afternoon or tomorrow. cdaiseyPhD@trade/the fingers.com

To: John Brickman who wrote (5514)	3/25/1998 11:12:00 AM
From: Hank	Read Replies (2) \| Respond to of 18691

Yeah. I finally found it. Jumping the gun a little aren't you? A patent is not an FDA approval to sell Vasomax. I can tell that patents are not all that difficult to get if you have a good patent lawyer. A minor change in formulation is all it takes to make the drug "unique". I still believe that Vasomax has no chance for FDA approval and if the price goes higher, I will short some more. Don't forget that the Viagra announcement is due to occur any day now. That should knock this thing down a peg or two.